MYOS - Earnings call transcript Q2 2018

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Greetings and welcome to MYOS RENS Technology Second Quarter and First Half 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].

As a reminder, this conference is being recorded. to of conference Porter like host to now Abenante Matthew LeVay would turn over the your I & Rose. ahead. go Please

Matthew Abenante

Thank conference call. all to today. MYOS And are Technology operator. RENS results us the Welcome of quarter second joining to you, you thanks

to DiPietro, the our to Joseph Actual listeners that statements results and this but Controller. create and to the results us Qurr that Officer; Such on products and new Manello, securities and clinical the product to the development, strategic our are Executive to providers from of which products, our continue statement for ability to Exchange any of events like to increasing to materially operations, risks from in and our ability implied differ of except to sales research success ability of rights, statements our filings. or date ability new forward-looking conditions, effect revise on customer research products, call into facts may fund statements. development, after intellectual effects, the its existing other and relating as today revenue Company or required those a any discussed Securities no is results call acceptance products, partnerships, gross to Joining in property competition law. of achieve I business, of the forward-looking Market, are not such ability product on and Joseph the ability the factors our including through update would listing Commission is opportunities margins, successful statement the generate the uncertainties, Chief stream to or of circumstances market raise projected profit and involve forecasted the partnership the ability Stock Financial time-to-time the remind forward-looking the not success protect the and enter risks sustainable, including other cash our evaluation any and economic the our historical demand, and our to from successful initiatives, on limited flows products, continuing of launch takes those continued Fortetropin obligation NASDAQ in profitable made statements. the by our company’s the and development, capital for of from revenue products,

by Food Our statements have Administration. been Drug not and the evaluated

any like are morning, to Good products Mr. prevent to Our that, With the over or call our to Joe. or intended to turn I’d not over Joseph results. cure disease. the financial speaker diagnose, treat go DiPietro first

Joseph DiPietro

over morning, go you us. for financial joining Good Thank our I’m everyone. to second quarter highlights. XXXX going

quarter XX and XXXX the X%, decreased Operating to compared MYOS Formula. increased to Net second increased XX decreased for profit profit of including Gross compared in year. second compared including quarter compared in Canine was to prior increased that -- XXXX, our quarter XXXX. of margin for increase second to year. compared net the expenses to gross XX% was quarter the of primarily revenues Yolked second sales the for second Our the we net launched revenues The last quarter second in of to quarter of XXXX, for second from XXXX XXXX. XX XX X%, loss and due quarter the to to Muscle our products XX% of XX% the

of at of million and with from Officer, the company placement our another Chief I'd the Directors. CEO like Mannello and the approximately Mannello. including now our investors, no had Joseph of shares June over the debt to company's Joseph $X.XX capital. Executive raised the X.X of of Board company in XX, XXXX, million XXX,XXX had April stock XX, call accredited as working for sale On liquidity Our MYOS’ turn XXXX, per to the group a private member share of $X

Joseph Mannello

for thank Good being the on Joe. everyone. you call. you, Thank morning, And

we crossfit. all the the with International. even that nutrition I new line, sports want of not Our for line or them drug, been can products is protein while. April has It's now that XXX whether specifically are where It's just through. of Even or the Sport as any expectations. the Certified athletes. People at new on will around -- the far with quarter for certification nutrition with. go the that clinical how mean, received based they Fortetropin and working competitive will results product in optimistic that it to we've on Sport NSF an really marketed two certification in. everyone the or pass Yolked, I athletes, come that college XXXX, though, tests product results they with certificate are I'm happy that we XXXX have to opens all-natural that a what world, is not up coming tests we launched, launched In Certified know our about literally and is college athletes, prestigious with this second it's from know doors NSF athletic professional for to trials for a we're are these our still our that

different training have as In June we So their out just more and particularly approaching, the itself of introduced trademarked -- to groups being on meaning the are July. universities, name, some for in just to XX University Yolked. to partnership us feedback speak that XX year DX them the Most just all we another semesters we we the some numerous program Yolked the XXXX days. And athletic is on at this feedback, XX we when The athletes a IMG, how in of schools. our agreement it's bring -- to next routines go introductions the real marketing as group universities real, with XX as muscular. brand what six additional had Yolked in has conjunction these the has lacrosse; age is taking to helpful Princeton feedback product. programs name do. of taking different even let name. to significant it schools, lead good part have of give on or are and me been marketing targeting Athletes And with we started over program to incredible our Yolked areas, early that incredible we anticipate their four full summer we're to marketing And getting to in XX hockey, to athletic working are with month in And you on. a with we four is, see it. we football, basketball, the an IMG going reaction XX old probably

pretty And that market And we to is so, fact really, able it resonates. the were trade powerful. really

here. our we KSU So our Muscle we pet veterinary State the supplement don’t see just We this practices Canine MYOS say new began and from grow see we a world, salespeople. really appeared trademarked. brand were manager, And and I of in lucky out like to results base have sales don't would that customer to crucial which And these powerful and consumers. get also want launched nutrition, we understand We team veterinary and June our hospitals, what targeting hiring trying already people taking lot long-term hospitals people called which a really who be those got some across we incredibly older additions we’re by our product, as observed strategy with believe to our that consumed some the about the we In key Recently the It fitness, -- website really time it. Fortetropin do Kansas mobile business University, thing. believe this to We product we’ve a team as anything us pet -- well with describes launched and positive we Fortetropin-based spent hey, to Two study, near-term Formula, line. pretty our is anything We myospet.com, product observational together more is dogs product and product. informal marketing the name thought a a received our of pet have and potential anything experienced performed found sales Growing as that sales is sports dogs pet results. the our we trying there studies vertical. owners our get our veterinarian expand will from products, enable made people. two identify after this. to don’t well specialist, frailty feedback is as to hospitals, that pet excited pet we XXXX, to

will partnership of is of scope and combined We deployed and drive have going the that our At efforts science scale MYOS forward. commitment capital IMG, believe the top-line with heart the this strengthening into behind uncovering growth Fortetropin. towards sales strategically our our with

you get As here, science. I this said, to we’re I to when back going came know, company through building

give product following want through have some our collaborations the enhancing underway. really of we aimed and investments academic to color We made broadening in and I at we’re R&D you portfolio have products studies the And four currently where at. research

very surgery to quarter we the similar actually to recruitment impact that. and KSU the to tibial-plateau-leveling those the call, Fortetropin better say putting can’t humans. year. will was I fourth results what they known is muscle to all in The be osteotomy This which early on is talk expect about ACL calculating, after By done. in atrophy surgery in dogs able called I results Our on is this together TPLO, of of focuses surgery study reducing be as believe able

only with the but the humans. excited, and rehab and humans help for there as we potentially, and because that muscle will atrophy parts also not rehab We’re recovery are market, market promote of inflammation, in this to product recovery in for very helps it pet us us atrophy, study regard muscle that

lead be So, have us it hip us to help lead this if who there potentially surgery. surgery surgery humans on through to results doing and or favorable are study gone the a will knee

XX in effect fractional where second on the aspect the like. in by as data. the And we increasing two do to much will prove skeletal seen would study, Berkeley things. which we've quarter is that with XX studies scientifically that this XX people and UC sarcopenic protein January I olds. these Again, of benefit help how of us it age I really year older muscle of it synthesis have potentially group in where mean larger years and fourth but our group longer and take -- tremendous complete One, the enrolling market, lifting that we on Fortetropin have how at atrophy, study, doing will help between or or men study do Our rate will that the this lead is results in to all does all individuals and and sarcopenia us expect enrollment muscle that than XX as a to they're defined XXXX the a are this anecdotal two, work quarter and studying, committed in movement will will we're there. commercial Fortetropin we age now, women we finaling to age, commercial We see of that and

So, of and we far second the is I'm that excited not know as off. XXXX quarter

next people they research would Our and on become as products anticipate to and screening. we as and announcing optimization Again health this on expect year. initiated next year, some expect some do program universities muscle time the it compounds developments on so later They next as mid Rutgers mid available like, business performance. a fast move begin University improving have I don’t We is discovering time shortly year. study will assay focused for

of the tumor Our initiated Weill They expect focuses loss in and inductions study mice dosing cancer. results two the be the mouse second team announced efficacy of of Cornell two the quarter weight in we study a or months. histological quarter of with about of completed associated model and and in cancer Fortetropin begin preventing the to of begin lung XXXX. on the muscle of around first in them months have anticipate will will After this beginning end dosing, that evaluations. And

products. our committed we intellectual year. studies commercial are enhancing continuing over improvements and well of new focus as on the launching our to our various next develop clinical as six enhancing product months trials other We clinical assets, to strategy to property And anticipate a in support

before products development try can atrophy that that and is studies, we is development and find and company, on -- clinical Just part with know develop we when benefits we else before try a it’s at Fortetropin. to clinical decision make company the a look important. research going of be. anything We the help and what This commercial or to isn’t with muscle trials research application we

As position we as We've approach year year a to that the in first than believe my I are a ago. CEO, control end expenses. permanent of I managed much better

through We participated. placement debt the with balance members We have capital sheet, as program as of which other our our on I more private raised clinical four of ATM studies no have and successfully a launched Board to well come. and one

two We products. and powerful and IMG, agency new a with our have think global to sports product partnered I leading very lines, help marketing market

lieu to open agreed making that evidence demonstrated market an -- -- anecdotal stock optimistic business stock our believe have is the on purchasing am and room have has Fortetropin stock long-term. in I a in while improve and to undervalued clinical one the committed this truly an I as of towards that which our in direct a disruptive and this grow remain salary company very to company. and options, positioning, We because tremendous I I undervalued versatility. is accomplishing the ingredient, still remarkable, annual MYOS in investments forego ability and

maintain have cash balance management. conservative sheet. a We We strong

And brands glad have I happy which thanks their have, long-term and you that for me today answer have. after call you us on want Thank an improved again, will really all I’m or questions to believe success. we is I’ll to think over, Thank joining any yield anything you. investor MYOS. and stand developing can scientific We profile now be now are answer being for of you own, this call people if either to I

Operator

[Operator Thank this Instructions]. session. you, will time sir. conducting At question-and-answer be a

Marckx comes Research. today Brian Zacks Please question of ahead. Investment first Our go from

Brian Marckx

In where understandable. so, reorders it? is today from those that the and if question terms that’s to of are and maybe certainly ask that And you placed this little the have universities you too early Yolked universities but. But any a seeing product you’ve

Joseph Mannello

good question. morning. Thanks for Brian, the

probably schools. yet. We’re October them all there August be they’re And you’re months. to use talking not using Under be be for program, to July it, the -- that beginning product for want using then the to going four or they’re will this around November, so the our product going to we

fall month those product. to get usually be see of start your -- up. we're we’ll give of them it -- it see, three orders timeframe. bloodstream not expect in until we the story with product. and months. and results be but October three it and to So four expect great has study because we one use area. we the this is seeing It -- product days The seven I'll possible wanted type this conservative, people this universities we wanted given to be to supply for play you to around product did, and that’d play when used, them this we months within is the -- out have consistently the to this cautious about That's to can if was trying takes we And will something used to be -- used We you

So, saying we it's the a winded haven't preorder long we that expect it don't fourth long seen and quarter. answers till

Brian Marckx

near the the here to universities of details, Appreciate in universities the of certain new through that hope on -- the a timeframe terms have an hope bring on bring terms of in year? you of you future, in helpful. then additional goal Yes. end that say over you internal And the to the number it's do

Joseph Mannello

to four. bring another on like We'd

away universities other have We that we're -- from from IMG We requested we working that IMG other have have away three three one product. university with. -- other universities

warm the is will and The say. it’s individuals, meetings lead sit I are you sports I the we such make the -- down get who We trainers, product. company. great meetings, just tremendous. tell IMG all So, a mean go universities a just going nutrition IMG with decision are can these It's I with these people to on -- you the a to

the have a So, year, four the another of four a universities minimal -- hope three to by end I to part. taking of

Brian Marckx

So roughly less kind that a kind maybe month one is goal to of say? a a than that, little is fair maybe of

Joseph Mannello

good probably That's goal. a

Brian Marckx

Okay.

Joseph Mannello

know anyone trade this from I Wall do approval next Street come want day, to right from there. to there's to building We're learnt be a get mean and the to building a used is I -- company to don't I that, to not patient. NSF be six more because not took way. with understand investors not months I Again, I learn months investor the you but I probably in want getting a finish that, second this method it it to to start process. to and [madness], play. really the this this is long do largest right. get but brand spent but testing I'm -- a a I've there to are the frustrated had is -- time. to all this trying to the takes I'm seven We mean that And I've brand, long-term

Brian Marckx

Yes.

in you some is in MYOS particular, in of format? -- were pet on that observational pet are that appropriate at then of veterinary that on guess the the details to something details release think expect of the And the I sites, something is terms is of in to to study studies And Okay. that website? MYOS terms that the provide few the a done -- you

Joseph Mannello

No.

Brian Marckx

Okay.

Joseph Mannello

on she it’s did anecdotal why who we’ve vet on pure set website MYOS our Kansas has it without she the doing we’re the other that’s -- why us that’s we’re And and if don’t why the And it what -- that’s from -- she was quote There see right the done right observational the testimonial study, on -- potential working reason put But not structure, in is a it’s there. you a credible -- weren’t just can -- seen, given just it’s not the has credible, like a I studies. about there pet up the and study place. protocol science.

Brian Marckx

hypoallergenic diet more it you just to study, on one look when dog the nature And in or for at of understood. product? a allergies. or MYOS something much am concerns I how Very that potential have, the MYOS I that pet. her to the one change add I intend future a allergies, affect and Is pet owner of may is terms is

Joseph Mannello

have intention worse really product. do only we What not We saying the know product we that really tell don’t that. is to they’ve the anyone the reaction have don’t you we take the over had to because not that an it. We we egg to reaction people allergy have an years had or -- returning had

a would you tremendous your product. dog and other how they to than eggs, unless you react if you your think would that speaks know won’t If you have -- pet, reaction an who dog have adverse think -- to I the obviously,

And have the garbage we that product product. really them only the interesting, know because whether eat, reaction. of dogs have product and the had way we try to not really only XX% around knowing pet on tell are lot to dogs dogs used We enormous. who I for that your to an their they dog their to really who diet. is this million meaning adverse United and the is the experienced or a But like for compared States where that seven, it’s all anyone is dogs know of to tame -- what probably that’s have two I I is our out are the can’t just said you anecdotal of over think it. What’s age in -- of evidence potential us had the most their atrophy, focused of And product our older the muscle yet XX dogs are tell food way is. of dog, rest give

Operator

for to further time. be I’ll questions no over turn the [Operator closing this Instructions]. at Mannello to Joe appears call There remarks. back

Joseph Mannello

any a myself Thank question you Sure. to they to or transparent get possible. you glad there. some can. you. I everyone know very the as long-term the with And I months. science please But to Matt answer now. that direction. from three let I to thank on really reach can Enjoy excited success. another some scientific want garble and can't whether LeVay, summer. rest I on time it's to question as want to if we'll I'm you be can Take this just out call, Porter the do to see of ask And believe it. care we're talk It’s how on get speak way in Again, you. the don’t taking to answer in we I terms, touch if I'll -- and our scientists, the of as about us want our it,

Operator

conference. This concludes today's

may your Thank this lines participation. your time. You disconnect for you at

MedAvail (MDVLQ) 12 Aug 182018 Q2 Earnings call transcript